Biocon, an Indian biotechnology company will raise its investments in Scotland which is seen to be an emerging destination for clinical development of drugs.
Biocon, an Indian biotechnology company will raise its investments in Scotland which is seen to be an emerging destination for clinical development of drugs. Biocon is reported to already have a close relationship with life sciences organizations in Scotland. There are more than 550 life sciences organizations in Scotland, employing more than 26,500 people. Scotland will serve to fill the gaps seen in India, according to the company’s Head Kiran Mazumdar-Shaw. Development work beyond the US is possible so long as the FDA standards are maintained.
During her visit, she attended her first meeting of the international advisory board of Scottish Enterprise. The board is part of the government-funded development body's ‘globalscot’ network, a group of 900 senior business leaders based overseas who try to help Scottish companies and the economy.The Financial Times report said that Mazumdar-Shaw was introduced to the network by John Shaw, her Scottish husband.
The report added that Mazumdar-Shaw was also excited by Scotland's potential as a base for epidemiological studies because of the links between the government, universities and life sciences companies. Epidemiological studies relate diseases and their causes by studying large populations.
Edited (IANS)
